Cefozopran hydrochloride (Cat No.:I000527) is a semi-synthetic, parenteral, fourth-generation cephalosporin with broad-spectrum antibacterial activity. It can effectively inhibit both Gram-negative and Gram-positive bacteria. As an antibiotic, cefozopran hydrochloride demonstrates efficacy against a wide range of bacterial infections.
| Catalog Number | I000527 |
| CAS Number | 113981-44-5 |
| Molecular Formula | C19H17N9O5S2•HCl |
| Purity | 95% |
| Target | Antibacterial |
| Solubility | H2O: ＞ 52 mg/mL |
| Storage | under inert gas (nitrogen or Argon) at 2-8°C |
| IUPAC Name | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrochloride |
| InChI | InChI=1S/C19H17N9O5S2.ClH/c1-33-24-11(14-23-19(20)35-25-14)15(29)22-12-16(30)28-13(18(31)32)9(8-34-17(12)28)7-26-5-6-27-10(26)3-2-4-21-27;/h2-6,12,17H,7-8H2,1H3,(H3-,20,22,23,25,29,31,32);1H/b24-11-;/t12-,17-;/m1./s1 |
| InChIKey | NTJHUKMPVIFDNY-XFDPNJHTSA-N |
| SMILES | CON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=C5C=CC=NN5C=C4)C(=O)[O-].Cl |
| Reference | <p style=/line-height:25px/> |
